TALPHERA, INC. Cash and Cash Equivalents, Period Increase (Decrease)
TALPHERA, INC. (TLPH) reported Cash and Cash Equivalents, Period Increase (Decrease) of $9.20 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-11
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $9.20M.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$7.26M, a 123.89% decline year-over-year.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$43.12M, a 277.51% decline year-over-year.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$8.24M.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$73.29M, a 308.97% decline from fiscal 2018.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $35.07M.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$27.41M.
- TALPHERA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$27.61M, a 157.66% decline from fiscal 2015.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 72 month | Cash and Cash Equivalents, Period Increase (Decrease) 75 month | Cash and Cash Equivalents, Period Increase (Decrease) 78 month | Cash and Cash Equivalents, Period Increase (Decrease) 81 month | Cash and Cash Equivalents, Period Increase (Decrease) 84 month | Cash and Cash Equivalents, Period Increase (Decrease) 87 month | Cash and Cash Equivalents, Period Increase (Decrease) 90 month | Cash and Cash Equivalents, Period Increase (Decrease) 93 month | Cash and Cash Equivalents, Period Increase (Decrease) 96 month | Cash and Cash Equivalents, Period Increase (Decrease) 99 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $9.20M 10-Q · filed 2020-05-11 | $1.94M derived: sum of 2 quarters · filed 2020-05-11 | -$41.19M derived: sum of 3 quarters · filed 2020-05-11 | -$49.43M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||
| 2019-12-31 | -$7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$50.39M derived: sum of 2 quarters · filed 2020-03-16 | -$58.63M derived: sum of 3 quarters · filed 2020-03-16 | -$73.29M 10-K · filed 2020-03-16 | ||||||||||
| 2019-09-30 | -$43.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$51.36M derived: sum of 2 quarters · filed 2019-11-07 | -$66.03M 10-Q · filed 2019-11-07 | -$35.62M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||
| 2019-06-30 | -$8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$22.90M 10-Q · filed 2019-08-06 | $7.50M derived: sum of 3 quarters · filed 2020-05-11 | $31.80M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||
| 2019-03-31 | -$14.66M 10-Q · filed 2020-05-11 | $15.75M derived: sum of 2 quarters · filed 2020-05-11 | $40.04M derived: sum of 3 quarters · filed 2020-05-11 | $29.71M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||
| 2018-12-31 | $30.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $54.70M derived: sum of 2 quarters · filed 2020-03-16 | $44.37M derived: sum of 3 quarters · filed 2020-03-16 | $35.07M 10-K · filed 2020-03-16 | ||||||||||
| 2018-09-30 | $24.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $13.96M derived: sum of 2 quarters · filed 2019-11-07 | $4.66M 10-Q · filed 2019-11-07 | -$10.37M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2018-06-30 | -$10.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$19.63M 10-Q · filed 2019-08-06 | -$34.66M derived: sum of 3 quarters · filed 2020-03-16 | -$28.88M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2018-03-31 | -$9.30M 10-Q · filed 2019-05-09 | -$24.33M derived: sum of 2 quarters · filed 2020-03-16 | -$18.55M derived: sum of 3 quarters · filed 2020-03-16 | -$28.73M derived: sum of 4 quarters · filed 2020-03-16 | ||||||||||
| 2017-12-31 | -$15.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$9.25M derived: sum of 2 quarters · filed 2020-03-16 | -$19.43M derived: sum of 3 quarters · filed 2020-03-16 | -$27.41M 10-K · filed 2020-03-16 | ||||||||||
| 2017-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$4.40M derived: sum of 2 quarters · filed 2018-11-05 | -$12.37M 10-Q · filed 2018-11-05 | -$24.53M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2017-06-30 | -$10.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$18.16M 10-Q · filed 2017-08-02 | -$30.31M derived: sum of 3 quarters · filed 2019-03-07 | -$35.65M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2017-03-31 | -$7.98M 10-Q · filed 2017-05-08 | -$20.13M derived: sum of 2 quarters · filed 2019-03-07 | -$25.47M derived: sum of 3 quarters · filed 2019-03-07 | -$33.10M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2016-12-31 | -$12.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$17.49M derived: sum of 2 quarters · filed 2019-03-07 | -$25.12M derived: sum of 3 quarters · filed 2019-03-07 | -$27.61M 10-K · filed 2019-03-07 | ||||||||||
| 2016-09-30 | -$5.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$12.97M derived: sum of 2 quarters · filed 2017-11-09 | -$15.46M 10-Q · filed 2017-11-09 | -$2.58M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2016-06-30 | -$7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$10.12M 10-Q · filed 2017-08-02 | $2.76M derived: sum of 3 quarters · filed 2018-03-09 | $61.96M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2016-03-31 | -$2.49M 10-Q · filed 2017-05-08 | $10.39M derived: sum of 2 quarters · filed 2018-03-09 | $69.59M derived: sum of 3 quarters · filed 2018-03-09 | $56.28M derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||
| 2015-12-31 | $12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $72.08M derived: sum of 2 quarters · filed 2018-03-09 | $58.78M derived: sum of 3 quarters · filed 2018-03-09 | $47.88M 10-K · filed 2018-03-09 | ||||||||||
| 2015-09-30 | $59.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $45.90M derived: sum of 2 quarters · filed 2016-11-02 | $35.00M 10-Q · filed 2016-11-02 | $24.80M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-06-30 | -$13.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$24.20M 10-Q · filed 2016-07-29 | -$34.40M derived: sum of 3 quarters · filed 2017-03-03 | -$41.89M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2015-03-31 | -$10.89M 10-Q · filed 2016-05-02 | -$21.10M derived: sum of 2 quarters · filed 2017-03-03 | -$28.58M derived: sum of 3 quarters · filed 2017-03-03 | -$28.44M derived: sum of 4 quarters · filed 2017-03-03 | ||||||||||
| 2014-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$17.69M derived: sum of 2 quarters · filed 2017-03-03 | -$17.55M derived: sum of 3 quarters · filed 2017-03-03 | -$28.36M 10-K · filed 2017-03-03 | ||||||||||
| 2014-09-30 | -$7.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$7.35M derived: sum of 2 quarters · filed 2015-11-03 | -$18.16M 10-Q · filed 2015-11-03 | $9.45M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$10.67M 10-Q · filed 2015-08-04 | $16.93M derived: sum of 3 quarters · filed 2016-03-07 | $55.81M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2014-03-31 | -$10.81M 10-Q · filed 2015-05-05 | $16.79M derived: sum of 2 quarters · filed 2016-03-07 | $55.67M derived: sum of 3 quarters · filed 2016-03-07 | $40.51M derived: sum of 4 quarters · filed 2016-03-07 | ||||||||||
| 2013-12-31 | $27.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | $66.48M derived: sum of 2 quarters · filed 2016-03-07 | $51.32M derived: sum of 3 quarters · filed 2016-03-07 | $40.47M 10-K · filed 2016-03-07 | ||||||||||
| 2013-09-30 | $38.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $23.72M derived: sum of 2 quarters · filed 2014-11-10 | $12.86M 10-Q · filed 2014-11-10 | $57.07M derived: sum of 4 quarters · filed 2015-03-13 | $60.80M 10-Q · filed 2013-11-05 | |||||||||
| 2013-06-30 | -$15.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$26.01M 10-Q · filed 2014-08-11 | $18.20M derived: sum of 3 quarters · filed 2015-03-13 | $14.38M derived: sum of 4 quarters · filed 2015-03-13 | $21.92M 10-Q · filed 2013-08-12 | |||||||||
| 2013-03-31 | -$10.85M 10-Q · filed 2014-05-08 | $33.36M derived: sum of 2 quarters · filed 2015-03-13 | $29.54M derived: sum of 3 quarters · filed 2015-03-13 | $32.61M derived: sum of 4 quarters · filed 2015-03-13 | $37.08M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $44.21M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $40.39M derived: sum of 2 quarters · filed 2015-03-13 | $43.46M derived: sum of 3 quarters · filed 2015-03-13 | $40.14M 10-K · filed 2015-03-13 | $47.93M 10-K · filed 2013-03-12 | |||||||||
| 2012-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$748.00K derived: sum of 2 quarters · filed 2013-11-05 | -$4.07M 10-Q · filed 2013-11-05 | $1.90M derived: sum of 4 quarters · filed 2014-03-17 | $3.72M 10-Q · filed 2012-11-06 | |||||||||
| 2012-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$252.00K 10-Q · filed 2013-08-12 | $5.72M derived: sum of 3 quarters · filed 2014-03-17 | -$11.22M derived: sum of 4 quarters · filed 2014-03-17 | $7.54M 10-Q · filed 2012-08-10 | |||||||||
| 2012-03-31 | -$3.33M 10-Q · filed 2013-05-08 | $2.64M derived: sum of 2 quarters · filed 2014-03-17 | -$14.29M derived: sum of 3 quarters · filed 2014-03-17 | -$28.74M derived: sum of 4 quarters · filed 2014-03-17 | $4.47M 10-Q · filed 2012-05-09 | |||||||||
| 2011-12-31 | $5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$10.97M derived: sum of 2 quarters · filed 2014-03-17 | -$25.41M derived: sum of 3 quarters · filed 2014-03-17 | $4.74M 10-K · filed 2014-03-17 | $7.79M 10-K · filed 2012-03-23 | |||||||||
| 2011-09-30 | -$16.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$31.38M derived: sum of 2 quarters · filed 2012-11-06 | -$1.23M 10-Q · filed 2012-11-06 | -$5.73M derived: sum of 4 quarters · filed 2013-03-12 | $1.82M 10-Q · filed 2011-11-08 | |||||||||
| 2011-06-30 | -$14.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $15.71M 10-Q · filed 2012-08-10 | $11.20M derived: sum of 3 quarters · filed 2013-03-12 | $16.99M derived: sum of 4 quarters · filed 2013-03-12 | $18.76M 10-Q · filed 2011-08-11 | |||||||||
| 2011-03-31 | $30.15M 10-Q · filed 2012-05-09 | $25.65M derived: sum of 2 quarters · filed 2013-03-12 | $31.43M derived: sum of 3 quarters · filed 2013-03-12 | |||||||||||
| 2010-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.28M derived: sum of 2 quarters · filed 2013-03-12 | -$4.09M 10-K · filed 2013-03-12 | |||||||||||
| 2010-09-30 | $5.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $408.00K 10-Q · filed 2011-11-08 | ||||||||||||
| 2010-06-30 | -$5.38M 10-Q · filed 2011-08-11 | |||||||||||||
| 2009-12-31 | $1.08M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |